Stephen K. Etridge

Publications

116

Citations

H-Index

1998

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Stephen K. Etridge is an author at GlaxoSmithKline (United Kingdom) specializing in medicinal chemistry, diversity-oriented synthesis, and derivatives.

Top concepts

MedicineChemistryDerivativesEngineeringBiochemistryPharmacologyDrug DiscoveryPharmacotherapyNatural SciencesOrganic Chemistry

Publications per year

1998–2019

Publications

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2: Conversion of the Key Intermediate SB-235349 to SB-214857-A

Richard J. Atkins, Adam Banks, Richard K. Bellingham et al. · Organic Process Research & Development · 2003 · 49 citations

A new synthesis of the GPIIb/IIIa receptor antagonist SB-214857-A

Ian P. Andrews, Richard J. Atkins, Neil F. Badham et al. · Tetrahedron Letters · 2001 · 29 citations

Molecular Pharmacology, G Protein-coupled Receptor, Medicine +6

The Electrophilic Fluorination of Enol Esters Using SelectFluor: A Polar Two‐Electron Process

Susanna H. Wood, Stephen K. Etridge, Alan R. Kennedy et al. · Chemistry - A European Journal · 2019 · 23 citations

Chemical Engineering, Medicinal Chemistry, Derivatives +14

A New and Convergent Synthesis of (2<i>S</i>)-7-(4,4‘-Bipiperidinylcarbonyl)-2,3,4,5- tetrahydro-4-methyl-3-oxo-1<i>H</i>-1,4-benzodiazepine-2-acetic Acid Using a Palladium-Catalysed Aminocarbonylation Reaction

Stephen K. Etridge, Jerome F. Hayes, Timothy C. Walsgrove et al. · Organic Process Research & Development · 1998 · 15 citations

Rows per page

1–4 of 4